...
首页> 外文期刊>The Journal of Steroid Biochemistry and Molecular Biology >Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma.
【24h】

Expression and localization of endocrine gland-derived vascular endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma.

机译:内分泌腺源性血管内皮生长因子(EG-VEGF)在人胰腺和胰腺腺癌中的表达和定位。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) was recently identified as the first tissue-specific angiogenic molecule. EG-VEGF (the gene product of PROK-1) appears to be expressed exclusively in steroid-producing organs such as the ovary, testis, adrenals and placenta. Since the human pancreatic cells retain steroidogenic activity, in the present study we ascertained whether this angiogenic factor is expressed in normal pancreas and pancreatic adenocarcinoma. Tissue samples from normal males (n=5), normal females (n=5) and from surgically resected adenocarcinomas (n=2) were processed for RT-PCR and immunohistochemical studies. Results from semi-quantitative analysis by RT-PCR suggest a distinct expression level for EG-VEGF in the different tissue samples. The relative amount of EG-VEGF mRNA in pancreas was more abundant in female adenocarcinoma (0.89) followed by male adenocarcinoma (0.71), than normal female (0.64) and normal male (0.38). The expression of mRNA for EG-VEGF in normal tissue was significantly higher in females than in males. All samples examined showed specific immunostaining for EG-VEGF. In male preparations, the positive labeling was localized predominantly within the pancreatic islets while in female preparations the main staining was detected towards the exocrine portion. Specific immunolabeling was also observed in endothelial cells of pancreatic blood vessels. Our data provide evidence that the human pancreas expresses the EG-VEGF, a highly specific mitogen which regulates proliferation and differentiation of the vascular endothelium. The significance of this finding could be interpreted as either, EG-VEGF is not exclusive of endocrine organs, or the pancreas should be considered as a functional steroidogenic tissue. The extent of the expression of EG-VEGF appears to have a dimorphic pattern in normal and tumoral pancreatic tissue.
机译:内分泌腺衍生的血管内皮生长因子(EG-VEGF)最近被确定为第一个组织特异性血管生成分子。 EG-VEGF(PROK-1的基因产物)似乎仅在产生类固醇的器官中表达,例如卵巢,睾丸,肾上腺和胎盘。由于人类胰腺细胞保留了类固醇生成活性,因此在本研究中,我们确定了这种血管生成因子是否在正常胰腺和胰腺腺癌中表达。对来自正常男性(n = 5),正常女性(n = 5)和手术切除的腺癌(n = 2)的组织样品进行了RT-PCR和免疫组织化学研究。 RT-PCR半定量分析的结果表明,不同组织样品中EG-VEGF的表达水平不同。女性腺癌(0.89),其次是男性腺癌(0.71),胰腺中EG-VEGF mRNA的相对含量比正常女性(0.64)和正常男性(0.38)丰富。雌性正常组织中EG-VEGF的mRNA表达明显高于雄性。所有检查的样品均显示出针对EG-VEGF的特异性免疫染色。在雄性制剂中,阳性标记主要定位在胰岛内,而在雌性制剂中,主要染色被检测到外分泌部分。在胰腺血管内皮细胞中也观察到了特异性免疫标记。我们的数据提供了证据,表明人类胰腺表达了EG-VEGF,这是一种高度特异性的有丝分裂原,可调节血管内皮的增殖和分化。这一发现的意义可以解释为:要么EG-VEGF并不排除内分泌器官,要么应将胰腺视为功能性类固醇生成组织。在正常和肿瘤的胰腺组织中,EG-VEGF的表达程度似乎具有双态性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号